BioDelivery Sciences acquires North American Marketing Authorizations for ONSOLIS
BioDelivery Sciences announced it has entered into an assignment and revenue sharing agreement with Meda under which Meda will transfer the marketing authorizations for ONSOLIS® for the U.S. and the right to seek marketing authorizations for ONSOLIS in Canada and Mexico, back to BDSI. January 27, 2015